Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies.
Peipei LiuÚna C McMenaminBrian T JohnstonPeter MurchieLisa IversenAmanda J LeePauline A J VissersChris R CardwellPublished in: British journal of cancer (2020)
Overall, we observed little consistent evidence of an increased risk of gastric cancer with PPI use.